By Turna Ray
This article was originally posted March 11.
Direct-to-consumer genomics firms may have agreed to come under compliance with the US Food and Drug Administration's medical device regulations, but they are not ready to give up the direct access business model.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
